Molecular Diagnostics

How COVID impacted Vietnam’s blood supply: Q&A with Dr Tran Ngoc Que (Part 2)

How COVID impacted Vietnam’s blood supply: Q&A with Dr Tran Ngoc Que (Part 2)

As in most countries, the COVID pandemic caused widespread disruption to blood donation initiatives in Vietnam. In the second of this two-part Q&A series, Dr Tran Ngoc Que, director of the National Blood Centre at the National Institute of Haematology and Blood Transfusion (NIHBT) in Hanoi, discusses how NIHBT helped coordinate the blood supply during […]

How COVID impacted Vietnam’s blood supply: Q&A with Dr Tran Ngoc Que (Part 2) Read More »

St Paul’s Hospital upgrades molecular lab for greater automation and consolidation

St Paul’s Hospital upgrades molecular lab for greater automation and consolidation

St Paul’s Hospital is a 500-bed private hospital in Hong Kong that recently invested in an automated molecular diagnostics system with a compact size, broad assay menu and simple, easy-to-use interface. The system will support the hospital’s testing workload for SARS-CoV-2 and other infectious diseases, enabling their lab to continue providing short turnaround times and

St Paul’s Hospital upgrades molecular lab for greater automation and consolidation Read More »

How clinical labs can drive precision oncology in Thailand: Q&A with Prof Manop Pithupakorn (Part 2)

How clinical labs can drive precision oncology in Thailand: Q&A with Prof Manop Pithupakorn (Part 2)

To understand how the clinical lab community can help bring precision oncology to Thailand, Lab Insights spoke with Prof Manop Pithukpakorn, a physician and geneticist in the Faculty of Medicine in Siriraj Hospital at Mahidol University, Thailand. Drawing on his experience as a clinician and researcher who holds leadership positions in several national cancer initiatives,

How clinical labs can drive precision oncology in Thailand: Q&A with Prof Manop Pithupakorn (Part 2) Read More »

Thailand’s emerging precision oncology ecosystem: Q&A with Prof Manop Pithupakorn (Part 1)

prof manop part 1

To learn more about how Thailand plans to build its precision oncology ecosystem, Lab Insights spoke with Prof Manop Pithukpakorn, a physician and geneticist who works in the Faculty of Medicine in Siriraj Hospital at Mahidol University, Thailand. Prof Manop shares insights from his experiences with the Siriraj Centre of Research Excellence in Precision Medicine

Thailand’s emerging precision oncology ecosystem: Q&A with Prof Manop Pithupakorn (Part 1) Read More »

State-of-the-art blood screening in South Korea: a case study from Hanmaeum Blood Center

State-of-the-art blood screening in South Korea: a case study from Hanmaeum Blood Center

In March 2022, Hanmaeum Blood Center in South Korea implemented a state-of-the-art integrated automation system to connect its nucleic acid amplification, immunology, clinical chemistry and post-analytical systems. In doing so, it became the first blood banking center in the country to integrate its molecular and serological testing operations, thus establishing it as one of the largest

State-of-the-art blood screening in South Korea: a case study from Hanmaeum Blood Center Read More »

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics

To learn more about how cervical cancer impacts the lives of women globally and the steps organisations are taking to eliminate this disease globally, please visit the Conquering Cancer campaign. Click here for videos related to the campaign.  This article is part of a new series on diagnostics within Women’s Health. We’ll be adding more

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics Read More »

Open vs. closed molecular testing platforms: choosing the right system for your clinical lab

Open vs. closed molecular testing platforms: choosing the right system for your clinical lab

With rapid evolution in the molecular platforms available for clinical testing, it can be challenging for lab managers to select the best option for their needs. Recently, one of the primary differences that has emerged in molecular platforms is open systems versus closed systems. A closed system is often described as “sample to answer” or

Open vs. closed molecular testing platforms: choosing the right system for your clinical lab Read More »

HPV screening and vaccination in Asia: overcoming barriers to access

HPV screening and vaccination in Asia: overcoming barriers to access

Cervical cancer is the 4th leading type of cancer amongst women in the world. Caused by human papillomavirus (HPV) infection, cervical cancer is highly preventable through the use of prophylactic measures like HPV vaccines and robust screening programmes. Through the launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer in late 2020,

HPV screening and vaccination in Asia: overcoming barriers to access Read More »

China viewpoint: fourth-generation HIV testing brings big benefits

Screenshot of china viewpoint 4th generation HIV testing brings big benefits talk

Early detection of HIV infection can facilitate timely interventions that improve treatment outcomes and prevent further transmission. Fourth-generation HIV tests, which simultaneously detect both HIV antibodies and p24 antigens, allow healthcare practitioners to detect the virus with greater speed and accuracy than more traditional approaches. In China, clinical guidelines and laboratory processes are evolving to

China viewpoint: fourth-generation HIV testing brings big benefits Read More »

Scroll to Top